EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young migraine sufferers: drug shows promise in landmark trial
Disease control OngoingThis study tests whether galcanezumab, a monthly injection, can prevent migraines in children and teens aged 6 to 17 with episodic migraine. Over 500 participants received either the drug or a placebo for 3 months. The goal is to see if the drug reduces the number of migraine day…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Botox-Like shots could cut migraine days in half
Prevention OngoingThis phase 3 study tests whether Dysport (a botulinum toxin type A) injections can prevent episodic migraine in adults. About 751 participants receive either Dysport or placebo injections every 12 weeks for up to 36 weeks. The goal is to see if the treatment reduces the number of…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: Ipsen • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC